Spyre Therapeutics, Inc. (NASDAQ:SYRE) Shares Bought by Wellington Management Group LLP
Wellington Management Group LLP grew its stake in Spyre Therapeutics, Inc. (NASDAQ:SYRE – Free Report) by 6.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,604,508 shares of the company’s stock after purchasing an additional 97,308 shares during the quarter. Wellington Management […]
More Stories
Onto Innovation FY2025 EPS Decreased by Cantor Fitzgerald
Onto Innovation Inc. (NYSE:ONTO – Free Report) – Stock analysts at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS)...
Citigroup Forecasts Strong Price Appreciation for Maplebear (NASDAQ:CART) Stock
Maplebear (NASDAQ:CART – Get Free Report) had its price target upped by research analysts at Citigroup from $55.00 to $57.00...
Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of Bio-Path (NASDAQ:BPTH – Get Free Report) in a research note issued...
UBS Group Issues Pessimistic Forecast for Cross Country Healthcare (NASDAQ:CCRN) Stock Price
Cross Country Healthcare (NASDAQ:CCRN – Get Free Report) had its price objective decreased by investment analysts at UBS Group from...
Citigroup Cuts Confluent (NASDAQ:CFLT) Price Target to $25.00
Confluent (NASDAQ:CFLT – Free Report) had its price target decreased by Citigroup from $37.00 to $25.00 in a report released...
Climb Global Solutions’ (CLMB) Outperform Rating Reaffirmed at Barrington Research
Climb Global Solutions (NASDAQ:CLMB – Get Free Report)‘s stock had its “outperform” rating reaffirmed by Barrington Research in a research...